{"lastName":"monnier","objectUrn":"urn:li:member:42839604","geoRegion":"San Francisco Bay Area","fullName":"justin monnier","firstName":"justin","currentPositions":[{"companyName":"Bolt Biotherapeutics, Inc. ","description":"Developing Next Generation Immuno-Stimulant ADCs for the Treatment of Cancer.","title":"Senior Scientist","companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"geographicArea":"California","country":"United States","city":"REDWOOD CITY","postalCode":"94063","line1":"900 CHESAPEAKE DRIVE"},"website":"http:\/\/boltbio.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/bolt-biotherapeutics-inc\/","industry":"Biotechnology"},"companyUrn":"urn:li:fs_salesCompany:28626108","tenureAtCompany":{"numYears":2,"numMonths":7},"startedOn":{"month":11,"year":2021}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1706130121236?e=1723075200&v=beta&t=nFmoGmlxaaLdyrYu4HUo9Z5MfPrT9dU-Na_tMuTw49o","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1706130121236?e=1723075200&v=beta&t=NLWz1J83-F_6qD74hnX5xF5o_up5rylcanXVoSB8_o0","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1706130121236?e=1723075200&v=beta&t=QFucZRJszR_eUEV0uPKZiGK3qbg5q32eRJR65d0YoLU","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1706130121236?e=1723075200&v=beta&t=PGOT8qUYDhOgWZqMUd9Z50vuicFsu3wvyg4YyJEZOfg","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQGs1A3DAdnqiw\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2015},"degree":"post-doctoral fellowship","eduId":253944231,"schoolUrn":"urn:li:fs_salesSchool:1792","school":"urn:li:fs_salesSchool:1792","fieldsOfStudy":["Immunology"],"schoolName":"Stanford University","startedOn":{"year":2009}},{"school":"urn:li:fs_salesSchool:1792","schoolName":"Stanford University","schoolUrn":"urn:li:fs_salesSchool:1792","eduId":253942680},{"endedOn":{"year":2004},"degree":"B.S.","eduId":31925932,"schoolUrn":"urn:li:fs_salesSchool:2517","school":"urn:li:fs_salesSchool:2517","fieldsOfStudy":["Immunology"],"startedOn":{"year":2000}},{"endedOn":{"year":2009},"degree":"PhD","eduId":31925936,"schoolUrn":"urn:li:fs_salesSchool:15094140","school":"urn:li:fs_salesSchool:15094140","fieldsOfStudy":["Molecular and Cellular Biology"],"startedOn":{"year":2004}}],"skills":[{"numOfEndorsement":7,"name":"Flow Cytometry"},{"numOfEndorsement":3,"name":"Cell Biology"},{"numOfEndorsement":7,"name":"Immunology"},{"numOfEndorsement":4,"name":"Molecular Biology"},{"numOfEndorsement":3,"name":"Western Blotting"},{"numOfEndorsement":4,"name":"Cell Culture"},{"numOfEndorsement":1,"name":"Immunofluorescence"},{"numOfEndorsement":0,"name":"qPCR"},{"numOfEndorsement":1,"name":"Molecular Cloning"},{"numOfEndorsement":4,"name":"Tissue Culture"},{"numOfEndorsement":2,"name":"Cell"},{"numOfEndorsement":0,"name":"Fluorescence Microscopy"},{"numOfEndorsement":2,"name":"PCR"},{"numOfEndorsement":0,"name":"Cancer Research"},{"numOfEndorsement":3,"name":"Biochemistry"},{"numOfEndorsement":0,"name":"Grant Writing"},{"numOfEndorsement":0,"name":"Proposal Writing"},{"numOfEndorsement":0,"name":"Written & Oral Presentation Skills"},{"numOfEndorsement":0,"name":"Technical Writing"},{"numOfEndorsement":1,"name":"Technical Leadership"},{"numOfEndorsement":0,"name":"Cross-functional Team Leadership"},{"numOfEndorsement":1,"name":"FACS"},{"numOfEndorsement":1,"name":"In Vivo"},{"numOfEndorsement":0,"name":"Animal Models"},{"numOfEndorsement":0,"name":"Tumor Immunology"},{"numOfEndorsement":0,"name":"Confocal Microscopy"},{"numOfEndorsement":0,"name":"Immunohistochemistry"},{"numOfEndorsement":0,"name":"Stem Cells"},{"numOfEndorsement":5,"name":"Cancer"},{"numOfEndorsement":2,"name":"Life Sciences"},{"numOfEndorsement":1,"name":"Antibodies"},{"numOfEndorsement":0,"name":"Oncology"},{"numOfEndorsement":1,"name":"Clinical Research"},{"numOfEndorsement":0,"name":"Research"},{"numOfEndorsement":3,"name":"Biotechnology"},{"numOfEndorsement":0,"name":"Mouse Models"},{"numOfEndorsement":0,"name":"Genetics"},{"numOfEndorsement":1,"name":"ELISA"},{"numOfEndorsement":0,"name":"Microscopy"},{"numOfEndorsement":0,"name":"Science"},{"numOfEndorsement":0,"name":"Assay Development"},{"numOfEndorsement":1,"name":"Drug Discovery"},{"numOfEndorsement":0,"name":"Pharmaceutical Industry"},{"numOfEndorsement":0,"name":"In Vitro"},{"numOfEndorsement":0,"name":"Monoclonal Antibodies"},{"numOfEndorsement":0,"name":"antibody lead generation"},{"numOfEndorsement":0,"name":"Immunoassays"},{"numOfEndorsement":0,"name":"Leadership Communications"}],"numOfConnections":607,"patents":[],"headline":"Senior Scientist immunology-discovery","courses":[],"certifications":[{"companyUrn":"urn:li:fs_salesCompany:1337","url":"https:\/\/www.linkedin.com\/learning\/certificates\/fa03acdf306fd9d2fbe3193febdb2696904ac734338689968ab33d37e84f600b?trk=backfilled_certificate","authority":"LinkedIn","name":"Improving Your Leadership Communications","company":"urn:li:fs_salesCompany:1337","startedOn":{"month":1,"year":2022}}],"memberBadges":{"premium":true,"openLink":true,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/justin-monnier-53041b12","organizations":[],"location":"San Francisco Bay Area","publications":[{"name":"Prokineticin 2\/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.","publishedOn":{"month":2,"day":28,"year":2008},"publisher":"World Journal of Gastroenterology","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18300343","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Cytokine properties of prokineticins","publishedOn":{"month":8,"year":2008},"publisher":"FEBS Journal","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18647349","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells.","publishedOn":{"month":12,"day":19,"year":2008},"publisher":"European Cytkine Network","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19103522","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Prokineticins in angiogenesis and cancer.","publishedOn":{"month":10,"day":28,"year":2010},"publisher":"Cancer Letter","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20633984","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.","publishedOn":{"month":1,"year":2012},"publisher":"European Journal of Cancer","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21778049","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells","publishedOn":{"month":7,"day":15,"year":2012},"publisher":"Journal of Immunology","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22696441","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.","publishedOn":{"month":7,"day":30,"year":2012},"publisher":"Journal of Experimental Medicine","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22753924","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Anti-Asialo GM1 NK Cell Depleting Antibody Does Not Alter the Development of Bleomycin Induced Pulmonary Fibrosis.","publishedOn":{"month":6,"day":12,"year":2014},"publisher":"Plos One","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24922516","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"publishedOn":{"month":1,"day":1,"year":2018},"description":"Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and\/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.","url":"https:\/\/www.google.com\/patents\/US20170002087","name":"Mobilizing anti-tumor immunity by targeting chemerin receptor CCRL2","publisher":"US patent :US20170002087 A1","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]},{"name":"Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model","publishedOn":{"month":4,"day":13,"year":2015},"publisher":"J Vis Exp.","url":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4541547\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKNrjQBt5M95l-2qj_RVb1fN_gqGEr7Quo,NAME_SEARCH,SAAq)"}]}],"positions":null,"posts":[{"createdAt":1715996520000,"insightId":"652b7a33-ebe4-4778-b441-79fce2a0c21f","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:jobSeeker:urn:li:member:42839604"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":18},{"type":"APPRECIATION","count":17}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7197411191176978433","threadUrn":"urn:li:ugcPost:7197411191176978433","reactionsCount":35,"commentsCount":2,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7197411191176978433","message":{"attributes":[{"start":74,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:boltbio"}}},{"start":355,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:biotech"}}},{"start":364,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:drugdiscovery"}}},{"start":379,"length":13,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:immunesystem"}}},{"start":393,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:humanhealth"}}},{"start":406,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:jobsearch"}}},{"start":418,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:opentowork"}}}],"text":"Hello All! \nI have been impacted by the recent reduction in work-force at #Boltbio. I am now open to pursuing a new drug discovery role focused on leveraging the immune system to treat human diseases at the principal scientist level or above. If you believe my skill set and experience align with your needs, please feel free to reach out to me directly. #biotech #drugdiscovery #immunesystem #humanhealth #jobsearch  #OpenToWork"},"entityUrn":"urn:li:ugcPost:7197411191176978433"}}}]}